BIOMAT Database Logo BIOMAT Database Logo

End-stage renal disease in patients with sickle cell disease. 2017

Ahmed M Alkhunaizi, and Adil A Al-Khatti, and Samir H Al-Mueilo, and Abdulrazack Amir, and Bedri Yousif
Specialty Medicine Department, Nephrology Section, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.

Sickle cell nephropathy is a severe complication of sickle cell disease (SCD) that has a wide range of manifestations, from asymptomatic microalbuminuria to end-stage renal disease (ESRD). The data on patients with SCD who develop ESRD are scarce. The aim of this study was to explore the course of patients with SCD who developed ESRD and received renal replacement therapy (RRT). The course of patients with SCD who developed ESRD and started dialysis at two centers in the Eastern Province of Saudi Arabia was retrospectively analyzed. Parameters included age at initiation of dialysis, survival until death or kidney transplantation, hospitalization due to pain crisis, disease-related parameters, and requirement for blood transfusion. Sixteen patients with SCD developed ESRD and started RRT with either hemodialysis or peritoneal dialysis. The mean age at initiation of dialysis was 46.6 years. The majority of patients (10 out of 16) were resistant to erythropoiesis-stimulating agents (ESA) and required blood transfusion repeatedly. Pain crises were infrequently encountered. Median survival was 54 months. Four patients received kidney transplantation with good outcome. In conclusion, most patients with SCD who developed ESRD were resistant to ESA and required repeated blood transfusion. The rate of hospitalization due to pain crisis was relatively low. Survival on dialysis was comparable to that of patients with no SCD, and the post-transplant course was relatively benign.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010343 Patient Admission The process of accepting patients. The concept includes patients accepted for medical and nursing care in a hospital or other health care institution. Voluntary Admission,Admission, Patient,Admission, Voluntary,Admissions, Patient,Admissions, Voluntary,Patient Admissions,Voluntary Admissions
D001803 Blood Transfusion The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed) Blood Transfusions,Transfusion, Blood,Transfusions, Blood
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000755 Anemia, Sickle Cell A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S. Hemoglobin S Disease,HbS Disease,Sickle Cell Anemia,Sickle Cell Disease,Sickle Cell Disorders,Sickling Disorder Due to Hemoglobin S,Anemias, Sickle Cell,Cell Disease, Sickle,Cell Diseases, Sickle,Cell Disorder, Sickle,Cell Disorders, Sickle,Disease, Hemoglobin S,Hemoglobin S Diseases,Sickle Cell Anemias,Sickle Cell Diseases,Sickle Cell Disorder

Related Publications

Ahmed M Alkhunaizi, and Adil A Al-Khatti, and Samir H Al-Mueilo, and Abdulrazack Amir, and Bedri Yousif
End stage renal disease in sickle cell disease: future directions.
October 1992, Postgraduate medical journal,
Ahmed M Alkhunaizi, and Adil A Al-Khatti, and Samir H Al-Mueilo, and Abdulrazack Amir, and Bedri Yousif
Iron Chelation Therapy With Deferasirox in Sickle Cell Disease With End-Stage Renal Disease.
April 2022, Cureus,
Ahmed M Alkhunaizi, and Adil A Al-Khatti, and Samir H Al-Mueilo, and Abdulrazack Amir, and Bedri Yousif
Response of patients with sickle cell anaemia and end-stage renal disease to erythropoietin treatment.
June 2010, NDT plus,
Ahmed M Alkhunaizi, and Adil A Al-Khatti, and Samir H Al-Mueilo, and Abdulrazack Amir, and Bedri Yousif
End-stage renal failure in sickle cell trait.
December 1979, The West Indian medical journal,
Ahmed M Alkhunaizi, and Adil A Al-Khatti, and Samir H Al-Mueilo, and Abdulrazack Amir, and Bedri Yousif
Renal transplantation in end-stage sickle cell nephropathy.
January 1999, Transplantation,
Ahmed M Alkhunaizi, and Adil A Al-Khatti, and Samir H Al-Mueilo, and Abdulrazack Amir, and Bedri Yousif
The morbidity and mortality of end stage renal disease in sickle cell disease.
May 2019, American journal of hematology,
Ahmed M Alkhunaizi, and Adil A Al-Khatti, and Samir H Al-Mueilo, and Abdulrazack Amir, and Bedri Yousif
High one year mortality in adults with sickle cell disease and end-stage renal disease.
November 2012, British journal of haematology,
Ahmed M Alkhunaizi, and Adil A Al-Khatti, and Samir H Al-Mueilo, and Abdulrazack Amir, and Bedri Yousif
The sickle cell trait and end stage renal disease in Salvador, Brazil.
January 2018, PloS one,
Ahmed M Alkhunaizi, and Adil A Al-Khatti, and Samir H Al-Mueilo, and Abdulrazack Amir, and Bedri Yousif
Dendritic Cell Dysfunction in Patients with End-stage Renal Disease.
June 2017, Immune network,
Ahmed M Alkhunaizi, and Adil A Al-Khatti, and Samir H Al-Mueilo, and Abdulrazack Amir, and Bedri Yousif
Renal ablation in patients with end-stage renal disease.
July 2011, VASA. Zeitschrift fur Gefasskrankheiten,
Copied contents to your clipboard!